Johnson & Johnson (NYSE: JNJ) is a Healthcare company (Drug Manufacturers - General) with a market capitalization of $680.2B. The Maz Rating grades it against the other companies in its sector.
Johnson & Johnson's current Maz Rating and its five factor grades are for members: log in to see them.
At $282.55, Johnson & Johnson trades at 42.8x trailing earnings, 6.8x sales and 8.5x book value, with an EV/EBITDA of 26.4. Over the last twelve months it generated about $99.3B of revenue and $15.9B of net income. It runs a gross margin of 67.6%, an operating margin of 25.2% and a net margin of 16.2%. It shows return on equity of 19.6%, return on invested capital of 15.0% and a free cash flow yield of 3.0%. On the balance sheet: a debt-to-equity ratio of 0.55 and a current ratio of 1.02. Over the past 52 weeks the share price ranged from $198.53 to $290.25, with a beta of 0.23.
Johnson & Johnson pays a dividend yielding 1.87%, with 79% of earnings paid out. Its Maz Dividend Score is 2.63 out of 5, ranked against the other dividend payers in its sector (Safety 2.03, Growth 2.37, Yield 3.23, Consistency 4.97).
40 Wall Street analyst ratings cover the stock: 21 Buy, 16 Hold and 3 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, Johnson & Johnson (JNJ) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 6.81% / 30% · (Cash+Inv) / Mkt Cap (36m) 2.63% / 30% · Interest income / Revenue 0.73% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 6.81% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 2.63% / 33% · Receivables / Mkt Cap (36m) 2.90% / 49% · Interest income / Revenue 0.73% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 6.81% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 2.63% / 33.33% · Receivables / Mkt Cap (24m) 2.90% / 33.33% · Interest income / Revenue 0.73% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 24.6% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 10.0% / 33.33% · Receivables / Avg Assets (4Q) 9.13% / 33.33% · Interest income / Revenue 0.73% / 5% | Pass |
| FTSE | Debt / Total Assets 22.6% / 33.33% · (Cash+ST Inv) / Total Assets 8.73% / 33.33% · (Cash+Recv) / Total Assets 18.3% / 33.33% · Interest income / Revenue 0.73% / 5% | Pass |
Yes. As of September 2026, Johnson & Johnson (JNJ) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Johnson & Johnson is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.73% of each dividend: Johnson & Johnson's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 27, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.